在1985年至2024年期间,药物重用对制药创新的影响
Sanae Akodad1, Xixian Niu2, Berta Secades2
1Institute for Interdisciplinary Innovation in Healthcare (I3h), Faculté de Médecine, Solvay Brussels School of Economics and Management, Université Libre de Bruxelles (ULB), Brussels, Belgium. sanae.akodad@ulb.be.
Communications medicine
|January 7, 2026
概括
药物重新使用,批准现有药物用于新用途,加速创新. 这一战略利用了事先验证的机制,大大减少了研发不确定性,加快了治疗的临床部署.
科学领域:
- 制药创新 制药创新 制药创新
- 药物开发 药物开发
- 监管科学是一种监管科学.
背景情况:
- 药物重新定位涉及批准现有药物用于新疗法指示.
- 随着研发成本的增加和消耗率的增加,人们对重新使用预先验证的机制产生了兴趣.
- 这项研究研究了药物重用对40年来制药创新的影响.
研究的目的:
- 评估药物再利用对制药创新的贡献.
- 分析批准模式,治疗重定向和药物重定向中的行业行为.
- 根据所有权转让,比较重新利用时间表.
主要方法:
- 构建了美国FDA批准的新分子实体和生物学的纵向数据集 (1985-2024).
- 定义重用严格地定义为一个独特的新疗法指示,通过监管文件进行验证.
- 对批准量,治疗过渡,申请者轨迹和发展间隔进行了描述性分析.
主要成果:
- 451种药物随后获得了新用途的批准,占已授权药物的很大一部分.
- 瘤学和神经学是治疗重定向和跨领域翻译的关键领域.
- 再利用的平均时间为7.2年,比新药更短,特别是当所有权保持在内部时.
结论:
- 药物的重新用途是制药创新的持续驱动力.
- 它有助于在各种疾病领域快速部署验证的临床机制.
- 重用扩大了治疗选择,并减轻了研发风险.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Products: Biologics, Biosimilars and Interchangeables
229
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
229
Drug Control Governance: Regulatory Bodies and Their Impact
485
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
485
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Prodrugs
4.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.0K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K


